Pfizer delves into diversity-focused clinical trial partnership
Just a few hours ago, Pfizer and digital therapeutics outlet Sidekick Health announced a product launch in the next step of a pre-existing partnership. And now, the pharma giant has a new partnership to announce.
Details are few so far, but the partnership is with a global clinical trial firm called Headlands Research, which describes itself as an “international network of clinical trial sites.” The main objective, according to a statement released Thursday, is to start the ground work and initiate research sites in areas with diverse populations. According to a statement from Headlands, that is part of its mission to increase diversity among clinical trial participants.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,600+ biopharma pros reading Endpoints daily — and it's free.